Updated insights on cardiac risks of CD19-directed chimeric antigen receptor T-cell therapy: a pharmacovigilance study

Immunotherapy, Ahead of Print.

Source: Immunotherapy - March 23, 2023 Category: Allergy & Immunology Authors: Yinghong Zhai Fangyuan Hu Borui Zhu Jinfang Xu Xiaojing Guo Wentao Shi Xiang Zhou Yi Zheng Xiao Xu Xiaofei Ye Jia He Feng Xu Source Type: research